Clinical Trial: Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy

U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601386) titled 'Safety and Efficacy of JMKX000189 for Chemotherapy-Induced Peripheral Neuropathy' on May 06.

Brief Summary: This Phase Ib clinical trial aims to evaluate the safety, tolerability, and preliminary efficacy of JMKX000189 tablets in participants with chemotherapy-induced peripheral neuropathy (CIPN).

Study Start Date: May 10

Study Type: INTERVENTIONAL

Condition: CIPN - Chemotherapy-Induced Peripheral Neuropathy

Intervention: DRUG: JMKX000189

JMKX000189 administered orally.

OTHER: Placebo

Placebo administered orally.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Shanghai Jeyou Pharmaceutical Co., Ltd.

Published by HT Digita...